Advertisement

Topics

BioMed Central Ltd Company Profile

19:22 EDT 24th September 2018 | BioPortfolio

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical research
All original research articles published by BioMed Central are made freely and permanently accessible online immediately upon publication. BioMed Central views open access to research as essential in order to ensure the rapid and efficient communication of research findings

Location

Science Navigation Group Middlesex House
34-42 Cleveland Street
London
London
W1T 4LB
United KIngdom

Contact

Phone: 44 (0)20 7323 0323
Fax: 44 (0)20 7631 9926
Email: info@biomedcentral.com


News Articles [154 Associated News Articles listed on BioPortfolio]

BioMed X and Roche announce research collaboration in the field of immunology

BioMed X announced the initiation of a new research collaboration with F. Hoffmann-La Roche Ltd in the field of immunology. Within the framework of the agreement, BioMed X will launch a global call fo...

Harbour BioMed gets rights to Glenmark's bispecific antibody

Glenmark Pharmaceuticals SA granted Harbour BioMed exclusive rights to develop and sell its bispecific antibody GBR1302 for solid tumors in Greater China. Harbour BioMed also retains a manufacturing o...

Q Biomed seeks FDA nod for new cancer bone pain drug facility

A regulatory filing was submitted to the FDA by Q BioMed for the approval of a new manufacturing facility that will produce S -More- 

Harbour BioMed raises $85m to accelerate growth of therapeutic pipeline

Harbour BioMed is engaged in the discovery and development of therapeutics for oncology and immunological diseases. The financing round was led by GIC Private Limited, and participants included The p...

Siloam Biosciences to be acquired by MiCo BioMed

South Korea-based MiCo BioMed, which makes biochemical and molecular diagnostic products, announced its acquisition of Cincin -More- 

Q BioMed takes final step to gaining FDA approval to manufacture its spearhead drug

Q BioMed Inc (OTCQB: QBIO) CEO Denis Corin tells Proactive Investors the commercial-stage biotech is taking the final step in the approval process of its bone pain relief treatment, the "spearhead'"...

Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

Harbour BioMed has signed a collaboration agreement with Kelun-Biotech Biopharmaceutical to develop and commercialise A167, an anti-PD-L1 antibody indicated for...Read More... The post Deals this week...

IRW-News: RavenQuest Biomed Inc.: RavenQuest BioMed kommentiert historisches Votum des Senats hinsichtlich Verabschiedung des kanadischen Cannabis Act

IRW-PRESS: RavenQuest Biomed Inc.: RavenQuest BioMed kommentiert historisches Votum des Senats hinsichtlich Verabschiedung des kanadischen Cannabis Act RavenQuest BioMed kommentiert historisches V...

PubMed Articles [674 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "double sword role of EZH2 in leukemia" Biomed. Pharmacother. 98 (2018) 626-635.

Comment on "Using Innovative Acoustic Analysis to Predict the Postoperative Outcomes of Unilateral Vocal Fold Paralysis".

Comparison of Complication Rates of Central Venous Catheters Versus Peripherally Inserted Central Venous Catheters in Pediatric Patients.

The purpose of our study is to compare the rate of central line-associated blood stream infections and venous thromboembolism in central venous catheters versus peripherally inserted central catheters...

Bridges of biomaterials promote nigrostriatal pathway regeneration.

Repair of central nervous system (CNS) lesions is difficulted by the lack of ability of central axons to regrow, and the blocking by the brain astrocytes to axonal entry. We hypothesized that by using...

Quantification of the Central Cardiovascular Network Applying the Normalized Short-time Partial Directed Coherence Approach in Healthy Subjects.

The central control of the autonomic nervous system (ANS) and the complex interplay of its components can be described by a functional integrated mode - the central autonomic network (CAN). CAN repres...

Clinical Trials [1812 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Direct Measurement of Ideal Depth of Central Line

Total of 89 patients undergoing elective cardiac surgery will be enrolled. Right CVC insertion begins at their intersection of the cricoid cartilage level and the triangular point where t...

Temperature Control in Central Fever in the Neuro-ICU

There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket ...

Effect of the Bevel Direction of Puncture Needle on Success Rate and Complications During Central Venous Catheterization

To test the hypothesis that approaching the internal jugular vein with the needle bevel down would produce less injury to the vessel wall compared to the bevel up approach during central v...

Companies [639 Associated Companies listed on BioPortfolio]

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Environmental Health journal

Environmental Health is an open access, peer-reviewed, online journal published by BioMed Central that considers manuscripts on all aspects of environmental and occupational medicine, and related stud...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

ILSI Biomed Israel 2011

The ILSI Biomed Israel 2011 is the central annual event of Israel's life science industry. It consists of an international professional conference, targeted at the best experts an...

Biomed

Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

More Information about "BioMed Central Ltd" on BioPortfolio

We have published hundreds of BioMed Central Ltd news stories on BioPortfolio along with dozens of BioMed Central Ltd Clinical Trials and PubMed Articles about BioMed Central Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMed Central Ltd Companies in our database. You can also find out about relevant BioMed Central Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record